Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Terminated
×
Autoimmune Diseases
×
Clear all
Filters
3
NCT03283826
2024-02-23
EMBOLD
Atara Biotherapeutics
Phase 1/2
Terminated
134 enrolled